Assessment of spin-lattice T1 and spin-spin T2 relaxation time measurements in breast cell cultures at 1.5 Tesla as a potential diagnostic tool in vitro
Abstract
Magnetic resonance imaging (MRI) is a critically important tool in current medicine. This dynamic diagnostic method allows for detailed and accurate imaging of the human body and diagnosis of metabolic changes by magnetic resonance spectroscopy (MRS) assays. Our work presented herein shows measurement of spin-lattice T1 and spin-spin T2 relaxation time as an indicator of changes in cellular morphology. MRI spin-lattice T1 and spin-spin T2 relaxation time measurements are innovative experiments that provide a detailed picture of the biological microenvironment within cell cultures. Here, we used two types of cell cultures: cancerous and healthy breast cells. By measuring spin-lattice T1 and spin-spin T2 relaxation time in cancerous and healthy cell cultures we can detect differences and morphological conditions of both cell lines. A number of observations indicate that MRI can detect differences between cancer and healthy cells. In order to obtain a high density of cells for our cellular MRI study, we grew the cells in 3D geometry. In this paper, we underline the potential of quantitative MRI in vitro for future cellular mapping of drug concentration and drug efficiency in cell culture. We have shown that MRI, which is used often for imaging of anatomy, is also a promising technology for specific morphological measurements of cells.
Keywords: magnetic resonance imagingcell culturesspin-lattice T1spin-spin T2 relaxation time
References
- Rabi II, Zacharias JR, Millman S, et al. Milestones in magnetic resonance: 'a new method of measuring nuclear magnetic moment' . 1938. J Magn Reson Imaging. 1992; 2(2): 131–133.
- Walecki J, Ziemiański A. Rezonans magnetyczny i tomografia komputerowa w praktyce klinicznej. Springer PWN, Warszawa. ; 1998: 12–21.
- Mirhej ME. PROTON SPIN RELAXATION BY PARAMAGNETIC MOLECULAR OXYGEN. Canadian Journal of Chemistry. 1965; 43(5): 1130–1138.
- Rummeny EJ, Reimer P, Heindel W. Obrazowanie ciała metodą rezonansu magnetycznego. ; 2010: 1–6.
- Elmaoglu M, Celik A. Rezonans magnetyczny podstawy fizyczne obrazowanie ułożenie pacjenta Protokoły. Medipage. ; 2015: 1–9.
- Zhang L, Zhang Z, Mason RP, et al. Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs. Sci Rep. 2015; 5: 9874.
- Yang DM, Huettner JE, Bretthorst GL, et al. Intracellular water preexchange lifetime in neurons and astrocytes. Magn Reson Med. 2018; 79(3): 1616–1627.
- Shi Y, Guenneau F, Wang X, et al. MnO-gated Nanoplatforms with Targeted Controlled Drug Release and Contrast-Enhanced MRI Properties: from 2D Cell Culture to 3D Biomimetic Hydrogels. Nanotheranostics. 2018; 2(4): 403–416.
- Bartusik D, Tomanek B. Detection of (19)F-labeled biopharmaceuticals in cell cultures with magnetic resonance. Adv Drug Deliv Rev. 2013; 65(8): 1056–1064.
- Wang H, Zhao M, Ackerman JL, et al. Saturation-inversion-recovery: A method for T measurement. J Magn Reson. 2017; 274: 137–143.
- Fanea L. Sfrangeu SA. Relaxation times mapping using magnetic resonance imaging. Roman Rep Phys. 2011; 63(2): 456–464.
- Gonet B. Obrazowanie magnetyczno-rezonansowe, Wydawnictwo Lekarskie PZWL Warszawa. ; 1997: 11–45.
- Treier R, Steingoetter A, Goetze O, et al. Fast and optimized T1 mapping technique for the noninvasive quantification of gastric secretion. J Magn Reson Imaging. 2008; 28(1): 96–102.
- Hsu JJ, Glover GH. Rapid MRI method for mapping the longitudinal relaxation time. J Magn Reson. 2006; 181(1): 98–106.
- Hsu JJ, Zaharchuk G, Glover GH. Rapid methods for concurrent measurement of the RF-pulse flip angle and the longitudinal relaxation time. Magn Reson Med. 2009; 61(6): 1319–1325.
- Hirasaki GJ, Lo SW, Zhang Y. NMR properties of petroleum reservoir fluids. Magn Reson Imaging. 2003; 21(3-4): 269–277.
- Franks F. Water a comprehensive treatise. The physics and physical chemistry of water, plenum-press, New. ; 1972: 235–237.
- Piechnik SK, Ferreira VM, Dall'Armellina E, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010; 12: 69.
- Cooper MA, Nguyen TD, Spincemaille P, et al. How accurate is MOLLI T1 mapping in vivo? Validation by spin echo methods. PLoS One. 2014; 9(9): e107327.
- Weingärtner S, Meßner NM, Budjan J, et al. Myocardial T-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI. J Cardiovasc Magn Reson. 2016; 18(1): 84.
- Hamdy A, Kitagawa K, Ishida M, et al. Native Myocardial T1 Mapping, Are We There Yet? Int Heart J. 2016; 57(4): 400–407.
- Heidenreich JF, Weng AM, Donhauser J, et al. T1- and ECV-mapping in clinical routine at 3 T: differences between MOLLI, ShMOLLI and SASHA. BMC Med Imaging. 2019; 19(1): 59.
- Chow K, Flewitt JA, Green JD, et al. Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping. Magn Reson Med. 2014; 71(6): 2082–2095.
- Costello BT, Springer F, Hare JL, et al. SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3 T. Int J Cardiovasc Imaging. 2017; 33(10): 1551–1560.
- Nordio G, Henningsson M, Chiribiri A, et al. 3D myocardial T mapping using saturation recovery. J Magn Reson Imaging. 2017; 46(1): 218–227.